Viewing Study NCT00547261


Ignite Creation Date: 2025-12-24 @ 12:46 PM
Ignite Modification Date: 2026-01-04 @ 9:00 AM
Study NCT ID: NCT00547261
Status: TERMINATED
Last Update Posted: 2009-04-17
First Post: 2007-10-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module